Losmapimod (GW856553X)

Catalog No. A12526

Losmapimod,也称为GW856553或GW856553X,是葛兰素史克(GlaxoSmithKline)开发的药物,可作为酶家族的选择性抑制剂,称为p38促分裂原活化蛋白激酶,其作用于p38α和p38β的pKi分别为8.1和7.6 。
Catalog Num A12526
M. Wt 383.46
Formula C22H26FN3O2
Purity >98%
Storage at -20°C 3 years Powder
CAS No. 585543-15-3
Synonyms GW856553, GW-856553, GW 856553, GW856553X
SMILES CC1=C(C=C(C=C1C2=NC=C(C=C2)C(=O)NCC(C)(C)C)C(=O)NC3CC3)F
Losmapimod,也称为GW856553或GW856553X,是葛兰素史克(GlaxoSmithKline)开发的药物,可作为酶家族的选择性抑制剂,称为p38促分裂原活化蛋白激酶,其作用于p38α和p38β的pKi分别为8.1和7.6 。
Targets
p38α p38β
8.1(pKi)7.6(pKi)
In vitro DMSO 72 mg/mL (187.76 mM)
Water Insoluble
Ethanol Warmed: 39 mg/mL
* <1 mg/ml means slightly soluble or insoluble.
* Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
0.1 mM 26.08 mL 130.39 mL 260.78 mL
0.5 mM 5.22 mL 26.08 mL 52.16 mL
1 mM 2.61 mL 13.04 mL 26.08 mL
5 mM 0.52 mL 2.61 mL 5.22 mL

*The above data is based on the productmolecular weight 383.46. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.